Eczema Trial, Recruiting (NCT07525505)

Eczema Trial, Recruiting NCT07525505 Sponsor: Bezmialem Vakif University Condition: Eczema

Printed from Voxsanity (voxsanity.com.au) — NCT07525505 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Eczema

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
A doctor has examined your ear and confirmed you have a specific type of ear inflammation called eczematous otitis externa (a skin condition affecting the ear canal)
You are experiencing at least one of the following in the affected ear: itching, discomfort, discharge, or pain
You are willing to take part and can sign a consent form agreeing to participate

Who may not be able to join:

You have a known allergy or sensitivity to black seed oil (Nigella sativa) or a steroid medication called mometasone furoate
You have used steroid creams, steroid medicines, or other ear treatments recently before joining the trial (confirm with trial site for the exact time period)
Your ear condition is caused by an infection that needs antibiotic treatment
You have had ear surgery in the past or have an unusual structure in your ear canal
You have a serious ongoing health condition that could affect your ability to take part in the study (confirm with trial site)
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90(212) 523 22 88

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07525505

Sponsor: Bezmialem Vakif University

Phase: Not Applicable

Status: Recruiting

Condition: Eczema

Trial contact: +90(212) 523 22 88

More information: https://clinicaltrials.gov/study/NCT07525505

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
A doctor has examined your ear and confirmed you have a specific type of ear inflammation called eczematous otitis externa (a skin condition affecting the ear canal)
You are experiencing at least one of the following in the affected ear: itching, discomfort, discharge, or pain
You are willing to take part and can sign a consent form agreeing to participate

Who may not be able to join:

You have a known allergy or sensitivity to black seed oil (Nigella sativa) or a steroid medication called mometasone furoate
You have used steroid creams, steroid medicines, or other ear treatments recently before joining the trial (confirm with trial site for the exact time period)
Your ear condition is caused by an infection that needs antibiotic treatment
You have had ear surgery in the past or have an unusual structure in your ear canal
You have a serious ongoing health condition that could affect your ability to take part in the study (confirm with trial site)
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Bezmialem Vakif University

Registry

ClinicalTrials.gov

Start date

12 January 2026

Est. completion

1 June 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Change in objective inflammatory findings of the external ear from baseline to Day 10

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov